The relationship will bolster Antidote’s DE&I initiatives in patient recruitment and support NMHA’s health equity mission to close the healthcare gap in minority and underserved communities NEW YORK--(BUSINESS WIRE)--Antidote Technologies (Antidot...
ARLINGTON, Va. & MILAN, Italy--(BUSINESS WIRE)--The Digital Therapeutics Alliance (DTA) and Healthware Group today announced a partnership to form a coalition convening thought leaders, policymakers, and professional and trade associations from across ...
Arlington, VA – Milan, Italy | 14 June 2022 – The Digital Therapeutics Alliance (DTA) and Healthware Group today announced a partnership to form a coa…
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today announced that it will donate an office building in Downtown Louisville to the University of Louisville (UofL) in support of the activities of UofL’s Health Equity Innovation Hub. The 8-st...
Twenty-five million Spanish speakers in the United States receive about a third less healthcare as language-based healthcare gaps continue to widen AUSTIN, Texas--(BUSINESS WIRE)--Everly Health Solutions, the enterprise division of Austin-based Everly...
Innovaccer’s remote patient monitoring has been recognized by AVIA Connect for its role in advancing virtual acute care solutions to healthcare providers. SAN FRANCISCO--(BUSINESS WIRE)--Today, Innovaccer Inc., the Health Cloud company, announced that...
NEW YORK--(BUSINESS WIRE)--Best In Class MD (BICMD) announced its expansion of expert medical opinion (EMO) services to include 72 subspecialties within Internal Medicine, Surgery, Psychiatry, Radiology, Oncology and Obstetrics & Gynecology. This m...
Happify Health and Almirall’s partnership kicks off with the launch of Claro, a digital wellness solution for people with psoriasis to help improve their mental wellbeing, in Spain, the U.K. and Italy. An estimated 20% to 30% of patients with moder...
LAS VEGAS--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (NASDAQ: PMCB) (PharmaCyte), a biotechnology company focused on developing cellular therapies for cancer, diabetes and malignant ascites using its signature live-cell encapsulation technology, Cell-i...
AUSTIN, Texas & LONDON--(BUSINESS WIRE)--Babylon (NYSE:BBLN) is set to join the broad-market Russell 3000® Index at the conclusion of the 2022 Russell indexes annual reconstitution, effective after the US market opens on June 27, according to a prelimi...